Index Performance
-5.30%
Synbio Average
+1.44%
IBB
Overview
Description
Synthetic biology companies identified by AI with human in the loop. Minimum $1b market cap.
- Inception Date01/08/2024
- WeightingCustom
- # of holdings25
What's inside?
Holdings
All holdings as of May 17, 2024
CSV download
| Vertex Pharmaceuticals, Inc. (VRTX) | 6.82% | $114.89B | 14.21% | 87.25% | 9.80 |
| Pfizer Inc. (PFE) | 6.40% | $162.29B | -18.61% | 70.56% | 3.92 |
| Neurocrine Biosciences, Inc. (NBIX) | 6.39% | $14.32B | 22.57% | 97.52% | 6.87 |
| Teva Pharmaceutical Industries Ltd. (TEVA) | 6.31% | $18.51B | 4.84% | 46.56% | 2.06 |
| Johnson & Johnson (JNJ) | 6.10% | $372.17B | -13.55% | 68.78% | 4.37 |
| BridgeBio Pharma, Inc. (BBIO) | 5.68% | $5.63B | 11,461.88% | 99.10% | 30.87 |
| Bristol Myers Squibb Co. (BMY) | 5.32% | $89.25B | 4.66% | 55.54% | 3.46 |
| Cerevel Therapeutics Holdings, Inc. (CERE) | 5.18% | $7.67B | N/A | N/A | N/A |
| Catalent, Inc. (CTLT) | 5.13% | $10.02B | 3.57% | 21.32% | 3.64 |
| Charles River Laboratories International, Inc. (CRL) | 4.45% | $11.42B | -1.73% | 31.65% | 4.10 |
| Denali Therapeutics, Inc. (DNLI) | 4.24% | $2.92B | -100.00% | N/A | 7.38 |
| Insmed, Inc. (INSM) | 4.01% | $3.68B | 15.77% | 75.21% | 15.22 |
| Certara, Inc. (CERT) | 3.63% | $2.59B | 7.04% | 45.91% | 8.14 |
| Amicus Therapeutics, Inc. (FOLD) | 3.47% | $2.83B | 27.97% | 85.76% | 8.91 |
| CRISPR Therapeutics AG (CRSP) | 3.21% | $4.77B | -99.50% | -10,177.58% | 13.62 |
| Twist Bioscience Corp. (TWST) | 2.91% | $2.74B | 25.13% | 41.01% | 6.41 |
| Intellia Therapeutics, Inc. (NTLA) | 2.89% | $2.53B | 129.53% | 91.32% | 37.01 |
| Schrödinger, Inc. (SDGR) | 2.73% | $1.45B | -43.51% | 51.61% | 8.71 |
| Prothena Corp. Plc (PRTA) | 2.70% | $1.21B | -97.69% | -1,674.00% | 8.91 |
| Recursion Pharmaceuticals, Inc. (RXRX) | 2.62% | $2.17B | 13.68% | -5.60% | 45.52 |
| Protagonist Therapeutics, Inc. (PTGX) | 2.21% | $1.80B | N/A | 99.68% | 4.82 |
| Beam Therapeutics, Inc. (BEAM) | 2.17% | $2.03B | -69.39% | 26.71% | 4.91 |
| Inhibrx, Inc. (INBX) | 2.06% | $1.82B | -100.00% | N/A | 1,046.33 |
| Morphic Holding, Inc. (MORF) | 1.76% | $1.46B | -100.00% | N/A | N/A |
| AbCellera Biologics, Inc. (ABCL) | 1.61% | $1.07B | -18.36% | 32.03% | 18.91 |
Market data by FactSet
